ORF Genetics

About:

ORF Genetics is a biotechnology company developing and manufacturing high-quality recombinant proteins, in bioengineered barley plants.

Website: http://www.orfgenetics.com

Top Investors: Technology Development Fund

Description:

ORF Genetics Ltd. is a privately owned company established in 2001. ORF Genetics is an innovative company that is committed to economically viable and enabling solutions for the production of recombinant proteins, such as growth factors and cytokines, using its Orfeus™ expression system. The company is approaching the medical scientific research community and the cell culture media and diagnostics market with its products. Their product portfolio has expanded steadily to meet the needs of their customers with biorisk-free growth factors and cytokines.

Total Funding Amount:

211M ISK

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kópavogur, Gullbringusysla, Iceland

Founded Date:

2001-01-01

Contact Email:

info(AT)orf.is

Founders:

Björn Lárus Örvar, Einar Mäntylä, Júlíus Kristinsson

Number of Employees:

11-50

Last Funding Date:

2013-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai